Jacob S. Aday, Ph.D.

CBD is good right? Errr maybe not... In this RCT, I gave high doses of THC 🌿 to people with schizophrenia. Pre-treatment with CBD did not reduce the effects... but doubled them! 🤯 Sometimes I'm not sure that science is for me 🤡.

If we had “evidence-based sex,” researchers who get little sex themselves would write manuals with standardized sex instructions. They’d then conduct research trials showing that instruction-manual sex is better than no sex Then they’d call it “evidence-based sex” and declare it…

I am surprised there isn’t more talk in the psychedelic space about Auvelity, which was FDA approved in 2022. Unless I’m mistaken, it is essentially microdosing a dissociative hallucinogen (DXM) while on Wellbutrin. en.m.wikipedia.org/wiki/Dextromet…

You think you’re pretty up-to-date on what’s going on in the psychedelic field, and then you see a study like this published 😂🐶 “Evaluating the Potential of Microdosing 1cp-LSD for the Treatment of Canine Anxiety: A One-Month Case Study” onlinelibrary.wiley.com/doi/10.1002/vm…

2/ Key finding: LSD shows extremely high affinity for serotonin 2A receptors - IC50 of 1.93 nM with near-complete occupancy (97%) at clinical doses. We also showed maximal occupancy from only 75 mcg, indicating any differences in effect above this are due to off-target effects.

Every night human beings go to sleep, lose all sense of their known reality, plunge into an abstract hyper-dimensional realm of infinite experience where time collapses, all moments instantly manifest, and then they wake up and just go about their day.

New in @NatureMedicine: ReSPCT "An international Delphi consensus for reporting of setting in psychedelic clinical trials" by @ChloePronovostM, Kyle Greenway, myself, and many ReSPCT Experts. "The ReSPCT guidelines and accompanying explanatory document provide a new standard for…

The world psychedelic community speaks! Global Psychedelic Survey (GPS) 2025 just finished, with >8000 responses in >15 languages from >100 countries! Stay tuned for the studies, which will reflect a unique and unprecedented community-based perspective on psychedelics.

🎉🎉 Congratulations to our 11 #UMichAnes faculty members who recently received promotions! Read more about this fantastic group and their accomplishments here ➡️ michmed.org/rwwxZ

He's done it again! @MichaelHaichin made a list of ~500 papers published in 2024 and invited a diverse group of researchers to share their thoughts on them. From debates around psychotherapy’s role in psychedelic therapy to awe, music, zebrafish, and reimbursement...

Participate in the Global Psychedelic Survey 2025 (GPS 2025), a large global study on psychedelic use. Sponsored by Uni of Michigan, closes May 16! Win 1 of 15 $100 Amazon gift cards. Take part: bit.ly/GPS2025-survey #GPS2025 #PsychedelicResearch #GlobalSurvey

🎙️Jacob Aday (@JacobSAday) talked with @NPR's "All Things Considered" this weekend about the Global Psychedelic Survey & the need for global perspectives in psychedelic research. Listen here: michmed.org/mDdqe

It's alive!! The Global Psychedelic Survey (GPS) 2025 has launched worldwide. Take the survey here: michiganpsychedelic.med.umich.edu/research/globa…

The Michigan Psychedelic Center will launch the Global Psychedelic Survey 2025 on May 1. Prior to its launch, Dr. George Mashour talks about psychedelics, the future of psychedelic research & how the survey aims to ensure a community voice in the work: michmed.org/Q9ry8